# Mayville Engineering Company, Inc.: financial statements, quarterly

MEC · NYSE · CIK 1766368 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mec.md) · [Financials](/companies/mec/financials.md) · [Filings](/companies/mec/filings.md) · [Insiders](/companies/mec/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mec/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [158](/filings/0001558370-24-014558.md) | [149 d](/filings/0001104659-26-023496.md) | [161](/filings/0001558370-25-006726.md) | [164](/filings/0001558370-25-010445.md) | [135](/filings/0001104659-25-106973.md) | [121 d](/filings/0001104659-26-023496.md) | [136](/filings/0001104659-26-056257.md) | [132](/filings/0001104659-26-091110.md) | [144](/filings/0001104659-25-106973.md) | [134 d](/filings/0001104659-26-023496.md) | [145](/filings/0001104659-26-056257.md) | [163](/filings/0001104659-26-091110.md) |
| Cost of revenue | $m | [139](/filings/0001558370-24-014558.md) | [130 d](/filings/0001104659-26-023496.md) | [140](/filings/0001558370-25-006726.md) | [141](/filings/0001558370-25-010445.md) | [118](/filings/0001104659-25-106973.md) | [111 d](/filings/0001104659-26-023496.md) | [120](/filings/0001104659-26-056257.md) | [119](/filings/0001104659-26-091110.md) | [128](/filings/0001104659-25-106973.md) | [125 d](/filings/0001104659-26-023496.md) | [134](/filings/0001104659-26-056257.md) | [145](/filings/0001104659-26-091110.md) |
| Operating income | $m | [5.9](/filings/0001558370-24-014558.md) | [5.4 d](/filings/0001104659-26-023496.md) | [7.6](/filings/0001558370-25-006726.md) | [8.2](/filings/0001558370-25-010445.md) | [5.7](/filings/0001104659-25-106973.md) | [23.0 d](/filings/0001104659-26-023496.md) | [1.6](/filings/0001104659-26-056257.md) | [0.1](/filings/0001104659-26-091110.md) | [0.0](/filings/0001104659-25-106973.md) | [(5.5) d](/filings/0001104659-26-023496.md) | [(7.7)](/filings/0001104659-26-056257.md) | [0.4](/filings/0001104659-26-091110.md) |
| Interest expense | $m | [3.9](/filings/0001558370-23-017215.md) | [3.6 d](/filings/0001558370-24-002598.md) | [3.4](/filings/0001558370-24-007250.md) | [3.0](/filings/0001558370-25-010445.md) | [2.7](/filings/0001104659-25-106973.md) | [2.0 d](/filings/0001104659-26-023496.md) | [1.6](/filings/0001104659-26-056257.md) | [1.4](/filings/0001104659-26-091110.md) | [3.4](/filings/0001104659-25-106973.md) | [3.8 d](/filings/0001104659-26-023496.md) | [3.7](/filings/0001104659-26-056257.md) | [3.5](/filings/0001104659-26-091110.md) |
| Income tax | $m | [0.6](/filings/0001558370-24-014558.md) | [(0.4) d](/filings/0001104659-26-023496.md) | [1.0](/filings/0001558370-25-006726.md) | [1.4](/filings/0001558370-25-010445.md) | [0.1](/filings/0001104659-25-106973.md) | [5.1 d](/filings/0001104659-26-023496.md) | [(0.0)](/filings/0001104659-26-056257.md) | [(0.2)](/filings/0001104659-26-091110.md) | [(0.7)](/filings/0001104659-25-106973.md) | [(5.0) d](/filings/0001104659-26-023496.md) | [(3.3)](/filings/0001104659-26-056257.md) | [(1.0)](/filings/0001104659-26-091110.md) |
| Net income | $m | [1.4](/filings/0001558370-24-014558.md) | [2.2 d](/filings/0001104659-26-023496.md) | [3.2](/filings/0001104659-25-106973.md) | [3.8](/filings/0001104659-25-106973.md) | [3.0](/filings/0001104659-25-106973.md) | [16.0 d](/filings/0001104659-26-023496.md) | [0.0](/filings/0001104659-26-091110.md) | [(1.1)](/filings/0001104659-26-091110.md) | [(2.7)](/filings/0001104659-25-106973.md) | [(4.4) d](/filings/0001104659-26-023496.md) | [(8.2)](/filings/0001104659-26-091110.md) | [(2.1)](/filings/0001104659-26-091110.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001558370-24-014558.md) | not reported | [0.16](/filings/0001558370-25-006726.md) | [0.18](/filings/0001558370-25-010445.md) | [0.14](/filings/0001104659-25-106973.md) | not reported | [0.00](/filings/0001104659-26-056257.md) | [(0.05)](/filings/0001104659-26-091110.md) | [(0.13)](/filings/0001104659-25-106973.md) | not reported | [(0.40)](/filings/0001104659-26-056257.md) | [(0.09)](/filings/0001104659-26-091110.md) |
| Basic EPS | $ per share | [0.07](/filings/0001558370-24-014558.md) | not reported | [0.16](/filings/0001558370-25-006726.md) | [0.18](/filings/0001558370-25-010445.md) | [0.14](/filings/0001104659-25-106973.md) | not reported | [0.00](/filings/0001104659-26-056257.md) | [(0.05)](/filings/0001104659-26-091110.md) | [(0.13)](/filings/0001104659-25-106973.md) | not reported | [(0.40)](/filings/0001104659-26-056257.md) | [(0.09)](/filings/0001104659-26-091110.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.3](/filings/0001558370-23-017215.md) | [0.7](/filings/0001558370-25-002369.md) | [0.3](/filings/0001558370-24-007250.md) | [0.3](/filings/0001558370-24-011270.md) | [0.2](/filings/0001558370-24-014558.md) | [0.2](/filings/0001104659-26-023496.md) | [0.2](/filings/0001558370-25-006726.md) | [0.2](/filings/0001558370-25-010445.md) | [1.2](/filings/0001104659-25-106973.md) | [1.5](/filings/0001104659-26-091110.md) | [2.1](/filings/0001104659-26-056257.md) | [2.2](/filings/0001104659-26-091110.md) |
| Current assets | $m | [158](/filings/0001558370-23-017215.md) | [135](/filings/0001558370-25-002369.md) | [146](/filings/0001558370-24-007250.md) | [140](/filings/0001558370-24-011270.md) | [126](/filings/0001558370-24-014558.md) | [113](/filings/0001104659-26-023496.md) | [122](/filings/0001558370-25-006726.md) | [114](/filings/0001558370-25-010445.md) | [142](/filings/0001104659-25-106973.md) | [128](/filings/0001104659-26-091110.md) | [147](/filings/0001104659-26-056257.md) | [159](/filings/0001104659-26-091110.md) |
| Total assets | $m | [525](/filings/0001558370-23-017215.md) | [497](/filings/0001558370-25-002369.md) | [500](/filings/0001558370-24-007250.md) | [488](/filings/0001558370-24-011270.md) | [466](/filings/0001558370-24-014558.md) | [446](/filings/0001104659-26-023496.md) | [448](/filings/0001558370-25-006726.md) | [434](/filings/0001558370-25-010445.md) | [586](/filings/0001104659-25-106973.md) | [564](/filings/0001104659-26-091110.md) | [578](/filings/0001104659-26-056257.md) | [589](/filings/0001104659-26-091110.md) |
| Current liabilities | $m | [81.5](/filings/0001558370-23-017215.md) | [71.7](/filings/0001558370-25-002369.md) | [79.1](/filings/0001558370-24-007250.md) | [81.8](/filings/0001558370-24-011270.md) | [71.4](/filings/0001558370-24-014558.md) | [64.6](/filings/0001104659-26-023496.md) | [72.9](/filings/0001558370-25-006726.md) | [69.6](/filings/0001558370-25-010445.md) | [78.0](/filings/0001104659-25-106973.md) | [74.8](/filings/0001104659-26-091110.md) | [89.7](/filings/0001104659-26-056257.md) | [93.9](/filings/0001104659-26-091110.md) |
| Total liabilities | $m | [298](/filings/0001558370-23-017215.md) | [267](/filings/0001558370-25-002369.md) | [266](/filings/0001558370-24-007250.md) | [250](/filings/0001558370-24-011270.md) | [228](/filings/0001558370-24-014558.md) | [194](/filings/0001104659-26-023496.md) | [198](/filings/0001558370-25-006726.md) | [187](/filings/0001558370-25-010445.md) | [341](/filings/0001104659-25-106973.md) | [323](/filings/0001104659-26-091110.md) | [346](/filings/0001104659-26-056257.md) | [263](/filings/0001104659-26-091110.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [227](/filings/0001558370-24-014558.md) | [230](/filings/0001104659-26-023496.md) | [234](/filings/0001104659-25-106973.md) | [238](/filings/0001104659-25-106973.md) | [238](/filings/0001104659-25-106973.md) | [252](/filings/0001104659-26-091110.md) | [250](/filings/0001104659-26-091110.md) | [247](/filings/0001104659-26-091110.md) | [245](/filings/0001104659-25-106973.md) | [241](/filings/0001104659-26-091110.md) | [232](/filings/0001104659-26-091110.md) | [325](/filings/0001104659-26-091110.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [19.6 d](/filings/0001558370-24-014558.md) | [26.7 d](/filings/0001104659-26-023496.md) | [10.6](/filings/0001558370-25-006726.md) | [23.3 d](/filings/0001558370-25-010445.md) | [17.9 d](/filings/0001104659-25-106973.md) | [38.0 d](/filings/0001104659-26-023496.md) | [8.3](/filings/0001104659-26-056257.md) | [15.0 d](/filings/0001104659-26-091110.md) | [1.9 d](/filings/0001104659-25-106973.md) | [13.4 d](/filings/0001104659-26-023496.md) | [(2.8)](/filings/0001104659-26-056257.md) | [1.4 d](/filings/0001104659-26-091110.md) |
| Capital expenditure | $m | [3.5 d](/filings/0001558370-24-014558.md) | [6.8 d](/filings/0001104659-26-023496.md) | [2.8](/filings/0001558370-25-006726.md) | [4.1 d](/filings/0001558370-25-010445.md) | [2.9 d](/filings/0001104659-25-106973.md) | [2.3 d](/filings/0001104659-26-023496.md) | [3.0](/filings/0001104659-26-056257.md) | [2.4 d](/filings/0001104659-26-091110.md) | [3.0 d](/filings/0001104659-25-106973.md) | [3.2 d](/filings/0001104659-26-023496.md) | [4.2](/filings/0001104659-26-056257.md) | [8.1 d](/filings/0001104659-26-091110.md) |
| Share repurchases | $m | [1.0 d](/filings/0001558370-24-014558.md) | [0.0 d](/filings/0001104659-26-023496.md) | not reported | not reported | [1.0 d](/filings/0001104659-25-106973.md) | [3.9 d](/filings/0001104659-26-023496.md) | [1.7](/filings/0001104659-26-056257.md) | [2.9 d](/filings/0001104659-26-091110.md) | [0.0 d](/filings/0001104659-25-106973.md) | [0.0 d](/filings/0001104659-26-023496.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.4](/filings/0001558370-23-017215.md) | [20.7](/filings/0001558370-24-007250.md) | [20.8](/filings/0001558370-24-011270.md) | [20.6](/filings/0001558370-24-014558.md) | [20.7](/filings/0001558370-25-006726.md) | [21.0](/filings/0001558370-25-010445.md) | [21.1](/filings/0001104659-25-106973.md) | [20.8](/filings/0001104659-26-056257.md) | [20.7](/filings/0001104659-26-091110.md) | [20.7](/filings/0001104659-25-106973.md) | [20.4](/filings/0001104659-26-056257.md) | [22.8](/filings/0001104659-26-091110.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,500,331 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091110.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.